VOR – vor biopharma inc. (US:NASDAQ)
Stock Stats
News
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $8.00 price target on the stock.
Vor Biopharma Inc. (NYSE: VOR) had its price target lowered by analysts at HC Wainwright from $17.50 to $13.00. They now have a "buy" rating on the stock.
Vor Biopharma Inc. (NYSE: VOR) had its price target lowered by analysts at Stifel Nicolaus from $12.00 to $5.00. They now have a "buy" rating on the stock.
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $7.00 price target on the stock.
Vor Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
Form ARS Vor Biopharma Inc. For: Dec 31
Form DEFA14A Vor Biopharma Inc.
Form DEF 14A Vor Biopharma Inc. For: May 22
Form 8-K Vor Biopharma Inc. For: Mar 31
Form EFFECT Vor Biopharma Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.